Registry of Treatment Outcomes in a Non-study Population of Symptomatic Metastasized Castration Resistant Prostate Cancer (mCRPC) Patients Treated With Radium-223
Latest Information Update: 18 Apr 2022
At a glance
- Drugs Radium 223 chloride (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms ROTOR
- 16 Feb 2019 Results presented at the 2019 Genitourinary Cancers Symposium
- 16 Feb 2019 Status changed from recruiting to completed, according to the results presented at the 2019 Genitourinary Cancers Symposium
- 24 Jul 2017 New trial record